Table 2 Characteristics of patients with clinically significant migraine by year
From: Epidemiology of clinically significant migraine in Israel: a retrospective database study
Characteristic | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|
Number of patients | 22 165 | 22 936 | 23 395 | 23 690 | 24 063 | 24 311 | |
Sex | Female (%) | 17 222 (77.7) | 17 745 (77.4) | 18 123 (77.5) | 18 334 (77.4) | 18 552 (77.1) | 18 795 (77.3) |
Male (%) | 4941 (22.3) | 5189 (22.6) | 5270 (22.5) | 5354 (22.6) | 5509 (22.9) | 5516 (22.7) | |
Age (mean ± SD) | 44.0 ± 14.4 | 44.5 ± 14.6 | 45.1 ± 14.8 | 45.7 ± 14.9 | 46.2 ± 15.1 | 46.8 ± 15.2 | |
Age category, y (%) | 19–29 | 4171 (18.8) | 4164 (18.2) | 4043 (17.3) | 3948 (16.7) | 3816 (15.9) | 3716 (15.3) |
30–39 | 4897 (22.1) | 4949 (21.6) | 4968 (21.2) | 4897 (20.7) | 4950 (20.6) | 4866 (20.0) | |
40–49 | 5194 (23.4) | 5345 (23.3) | 5416 (23.2) | 5406 (22.8) | 5363 (22.3) | 5334 (21.9) | |
50–59 | 4416 (19.9) | 4581 (20.0) | 4677 (20.0) | 4775 (20.2) | 4924 (20.5) | 4982 (20.5) | |
60–69 | 2592 (11.7) | 2801 (12.2) | 3026 (12.9) | 3229 (13.6) | 3375 (14.0) | 3531 (14.5) | |
70–79 | 723 (3.3) | 869 (3.8) | 1004 (4.3) | 1162 (4.9) | 1334 (5.5) | 1558 (6.4) | |
80–89 | 150 (0.7) | 199 (0.9) | 226 (1.0) | 239 (1.0) | 260 (1.1) | 282 (1.2) | |
≥ 90 | 22 (0.1) | 28 (0.1) | 35 (0.2) | 34 (0.1) | 41 (0.2) | 42 (0.2) | |
SES (%) | 1–20 (mean ± SD) | 9.1 ± 3.6 | 9.0 ± 3.6 | 9.0 ± 3.6 | 9.0 ± 3.6 | 8.9 ± 3.6 | 8.9 ± 3.6 |
Data not available | 1306 (5.9) | 1438 (6.3) | 1487 (6.4) | 1508 (6.4) | 1641 (6.8) | 1633 (6.7) | |
SES category (%) | 0–5 | 3858 (18.5) | 4086 (19.0) | 4247 (19.4) | 4365 (19.7) | 4535 (20.2) | 4666 (20.6) |
6–8 | 5064 (24.3) | 5156 (24.0) | 5274 (24.1) | 5389 (24.3) | 5453 (24.3) | 5549 (24.5) | |
9–11 | 6626 (31.8) | 6860 (31.9) | 6953 (31.7) | 6992 (31.5) | 7001 (31.2) | 7033 (31.0) | |
≥ 12 | 5311 (25.5) | 5396 (25.1) | 5434 (24.8) | 5436 (24.5) | 5433 (24.2) | 5430 (23.9) | |
Data not available | 1306 (5.9) | 1438 (6.3) | 1487 (6.4) | 1508 (6.4) | 1641 (6.8) | 1633 (6.7) | |
Region (%) | Center | 6077 (27.4) | 6233 (27.2) | 6369 (27.2) | 6445 (27.2) | 6522 (27.1) | 6584 (27.1) |
Jerusalem | 3153 (14.2) | 3238 (14.1) | 3365 (14.4) | 3451 (14.6) | 3547 (14.7) | 3631 (14.9) | |
North | 6585 (29.7) | 6928 (30.2) | 7045 (30.1) | 7124 (30.1) | 7262 (30.2) | 7309 (30.1) | |
South | 6350 (28.6) | 6537 (28.5) | 6616 (28.3) | 6670 (28.2) | 6732 (28.0) | 6787 (27.9) | |
Ethnic category (%) | General | 15 236 (68.7) | 15 562 (67.9) | 15 713 (67.2) | 15 764 (66.5) | 15 803 (65.7) | 15 853 (65.2) |
Arab | 4770 (21.5) | 5074 (22.1) | 5260 (22.5) | 5452 (23.0) | 5712 (23.7) | 5822 (24.0) | |
Jewish Ultra-orthodox | 2159 (9.7) | 2300 (10.0) | 2422 (10.4) | 2474 (10.4) | 2548 (10.6) | 2636 (10.8) | |
Duration of migraine diagnosis (%) | 0–2 | 3280 (14.8) | 3396 (14.8) | 3059 (13.1) | 2647 (11.2) | 2769 (11.5) | 2758 (11.3) |
≥ 3 | 18 885 (85.2) | 19 540 (85.2) | 20 336 (86.9) | 21 043 (88.8) | 21 294 (88.5) | 21 553 (88.7) | |
BMI (kg/m2) (%) | (mean ± SD) | 27.0 ± 5.6 | 27.1 ± 5.6 | 27.2 ± 5.7 | 27.4 ± 5.7 | 27.4 ± 5.8 | 27.4 ± 5.8 |
Data not available | 2571 (11.6) | 2341 (10.2) | 2078 (8.9) | 2072 (8.8) | 2186 (9.1) | 1989 (8.2) | |
BMI category (%) | < 18.5 Underweight | 528 (2.7) | 545 (2.7) | 544 (2.6) | 515 (2.4) | 555 (2.5) | 609 (2.7) |
18.5–24.9 Normal | 7226 (36.9) | 7419 (36.0) | 7584 (35.6) | 7547 (34.9) | 7589 (34.7) | 7742 (34.7) | |
25–29.9 Overweight | 6711 (34.3) | 7101 (34.5) | 7318 (34.3) | 7447 (34.5) | 7475 (34.2) | 7484 (33.5) | |
≥ 30 Obese | 5129 (26.2) | 5530 (26.9) | 5871 (27.5) | 6109 (28.3) | 6258 (28.6) | 6487 (29.1) | |
Data not available | 2571 (11.6) | 2341 (10.2) | 2078 (8.9) | 2072 (8.8) | 2186 (9.1) | 1989 (8.2) | |
Migraine diagnosis by family physician during the year (%) | 5548 (25.0) | 5486 (23.9) | 5291 (22.6) | 4854 (20.5) | 4803 (20.0) | 4660 (19.2) | |
Migraine diagnosis by pain physician (%) | 56 (0.3) | 60 (0.3) | 58 (0.3) | 58 (0.2) | 62 (0.3) | 63 (0.3) | |
Criterion outpatient diagnosis by neurologist (%) | 14,769 (66.6) | 15 136 (66.0) | 15 436 (66.0) | 15 631 (66.0) | 15 916 (66.1) | 16 227 (66.7) | |
Criterion at least 2 chronic migraine diagnoses (%) | 17 741 (80.0) | 18 281 (79.7) | 18 752 (80.2) | 19 027 (80.3) | 19 240 (80.0) | 19 492 (80.2) | |
Criterion hospital diagnosis (%) | - | 172 (0.8) | 309 (1.3) | 416 (1.8) | 492 (2.0) | 589 (2.4) | |
Criterion inpatient diagnosis (%) | - | 163 (0.7) | 292 (1.3) | 366 (1.5) | 439 (1.8) | 537 (2.2) | |
Criterion migraine triptan use (%) | 4246 (19.2) | 4237 (18.5) | 4151 (17.7) | 3939 (16.6) | 4156 (17.3) | 3990 (16.4) | |
Criterion migraine CGRP use (%) | - | - | - | 24 (0.1) | 132 (0.6) | 232 (1.0) | |